Bill Aims to Protect Patient Access to Medication Information

April 3, 2023 by Dan McCue
Bill Aims to Protect Patient Access to Medication Information
Rep. Jared Golden, D-Maine

WASHINGTON — A bill introduced by Rep. Jared Golden, D-Maine, aims to ensure that rural Americans and senior citizens have access to information about their prescription medications — even without internet access.

“Many rural Mainers and seniors don’t have reliable access to the internet or aren’t comfortable using it to get important information about their prescription medications,” Golden said as he explained the motivation behind the Patients’ Right to Know Their Medication Act of 2023.

“Our bipartisan bill requires information about medications to be printed, ensuring that every American who relies on a prescription has all the information they need to take it safely when they leave the pharmacy,” he continued, adding, “This commonsense bill also would support hundreds of good jobs in Madawaska and our state’s forest products industry.” 

Joining Golden in sponsoring the bill are Reps. Buddy Carter, R-Ga., Dutch Ruppersberger, D-Md., and Bruce Westerman, R-Ark. 

Pharmacies often provide printed medication information for patients; however, they are not required to do so under current law, the representatives said.

As a result, some patients never receive important information on the safety, dosage and other details of their prescriptions with important health consequences. 

Printed information is particularly important in rural areas where internet access is often unreliable and for senior populations who don’t regularly use computers. 

The introduction of this bill also marks another step in the fight to protect the hundreds of good-paying Maine jobs at the Twin Rivers Paper Company’s Madawaska Paper Mill. 

In 2021, Golden successfully worked to defeat an amendment backed by the pharmaceutical lobby that would have required prescription drug manufacturers to distribute information electronically rather than include a paper insert. 

Twin Rivers Paper in Madawaska is the leading manufacturer of the paper inserts and employs over 500 people.

The Patients’ Right to Know Their Medication Act has been referred to the House Committee on Energy and Commerce.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • access to information
  • Jared Golden
  • labeling
  • packaging
  • prescription drugs
  • In The News

    Health

    Voting

    Prescription Drugs

    FDA Approves Painkiller Designed to Eliminate the Risk of Addiction Associated With Opioids

    WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of... Read More

    WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or... Read More

    January 29, 2025
    by Tom Ramstack
    Kennedy Downplays Vaccine Statements During Health Dept. Confirmation Hearing

    WASHINGTON — Robert F. Kennedy Jr. tried to deflect accusations of being a junk science advocate Wednesday during his Senate... Read More

    WASHINGTON — Robert F. Kennedy Jr. tried to deflect accusations of being a junk science advocate Wednesday during his Senate confirmation hearing to become secretary of the U.S. Department of Health and Human Services. Much of his time was spent defending his previous statements against vaccines... Read More

    J&J Buys Intra-Cellular in $14.6B Deal, Delving Further Into Central Nervous System Disorders

    Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders... Read More

    Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said Monday that it will pay $132 in cash for each share of Intra-Cellular. That represents a 39%... Read More

    October 3, 2024
    by Dan McCue
    Sickle Cell Drug Withdrawn Over Safety Concerns

    NEW YORK — Pfizer has voluntarily withdrawn the sickle cell treatment Oxbryta (voxelotor) from all markets in which it was... Read More

    NEW YORK — Pfizer has voluntarily withdrawn the sickle cell treatment Oxbryta (voxelotor) from all markets in which it was approved after concluding “the overall benefit” of the drug “no longer outweighs the risk.” The move comes after the European Medicines Agency announced it is reviewing... Read More

    September 25, 2024
    by Tom Ramstack
    Sens Denounce Higher Drug Prices Paid by Americans

    WASHINGTON — Some senators on Tuesday accused the chief executive officer of a pharmaceutical company of price-gouging on the leading... Read More

    WASHINGTON — Some senators on Tuesday accused the chief executive officer of a pharmaceutical company of price-gouging on the leading diabetes and weight loss drugs it sells to Americans. They said the far cheaper prices paid for the same drugs in Canada, France, Germany and Denmark... Read More

    August 15, 2024
    by Dan McCue
    Administration Unveils First 10 Negotiated Drug Prices

    WASHINGTON — The Biden administration on Thursday unveiled the results of the first-ever negotiations between Medicare and some of the... Read More

    WASHINGTON — The Biden administration on Thursday unveiled the results of the first-ever negotiations between Medicare and some of the world’s largest pharmaceutical companies. The landmark price negotiations were set in motion with the passage, by a 220-207 party-line vote in the House, of the Inflation... Read More

    News From The Well
    scroll top